Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (3) , 107-109
- https://doi.org/10.1016/s0165-6147(03)00027-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patientsBrain Research, 2001
- Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug ActionsThe Neuroscientist, 1999
- 5-Hydroxytryptamine2-Family Receptors (5-Hydroxytryptamine2A, 5-Hydroxytryptamine2B, 5-Hydroxytryptamine2C) Where Structure Meets FunctionPharmacology & Therapeutics, 1998
- Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the κ2 receptor in guinea pig brainPeptides, 1995
- Salvia divinorum and salvinorin A: new pharmacologic findingsJournal of Ethnopharmacology, 1994
- Opioid receptor density changes in Alzheimer amygdala and putamenBrain Research, 1993
- The Absolute Stereochemistry of SalvinorinsChemistry Letters, 1990
- Studies ofSalvia divinorum (Lamiaceae), an Hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central MexicoEconomic Botany, 1987
- Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorumThe Journal of Organic Chemistry, 1984
- Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)Journal of the Chemical Society, Perkin Transactions 1, 1982